TO
Tomas P Olsson

Elite Scholar

1,178
Works
60,851
Citations
120
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Tomas P Olsson

Also known as: OLSSON T, OLSSON T., Olsson T, Olsson TP, Olsson Tomas

1,178

Total Works

60,851

Citations

120

H-Index

642

i10-Index

Citation & Works Trend by Year
50 years active
Top Research Topics
Multiple Sclerosis Research Studies (886) Psoriasis: Treatment and Pathogenesis (247) T-cell and B-cell Immunology (236) Genetic Associations and Epidemiology (221) Peripheral Neuropathies and Disorders (155)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Leisure-time physical activity, sun exposure, and multiple sclerosis risk: a population-based case–control study Journal of Neurology 0
2026 Family history of multiple sclerosis and long-term outcomes Journal of Neurology 0
2026 Genetic modification of obesity-associated disability progression in multiple sclerosis Journal of Neurology 1
2026 Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility Nature Genetics 5
2026 Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells Proceedings of the National Academy of Sciences 1
2026 DNA methylation landscape of cerebrospinal fluid cells in multiple sclerosis: an epigenome-wide association study EBioMedicine 0
2026 Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models Science Translational Medicine 0
2026 Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome Brain 0
2026 Lymphocyte count polygenicity underlies dimethyl fumarate–associated lymphopenia in multiple sclerosis Multiple Sclerosis Journal 0
2026 Shared etiology of late- and adult-onset multiple sclerosis Multiple Sclerosis Journal 0
2026 HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis Journal of Neurology Neurosurgery & Psychiatry 1
2026 Dental amalgam exposure and multiple sclerosis: authors’ response International Journal of Epidemiology 0
2026 Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years Multiple Sclerosis and Related Disorders 0
2026 Targeting progressive multiple sclerosis: Toward mechanism‐informed precision medicine Journal of Internal Medicine 1
2026 Interaction between smoking and HLA-A*02:01 in multiple sclerosis progression Multiple Sclerosis Journal 3

Data source: OpenAlex API